Crossmark

Fragile X Messenger Ribonucleoprotein 1 (FMR1), a novel inhibitor of osteoblast/osteocyte differentiation, regulates bone formation, mass, and strength in young and aged male and female mice

Crossref DOI link: https://doi.org/10.1038/s41413-023-00256-x

Published Online: 2023-05-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Deosthale, Padmini

Balanta-Melo, Julián https://orcid.org/0000-0002-0138-9199
Creecy, Amy

Liu, Chongshan

Marcial, Alejandro

Morales, Laura

Cridlin, Julita

Robertson, Sylvia

Okpara, Chiebuka

Sanchez, David J.

Ayoubi, Mahdi

Lugo, Joaquín N.

Hernandez, Christopher J. https://orcid.org/0000-0002-0712-6533
Wallace, Joseph M. https://orcid.org/0000-0001-6077-8058
Plotkin, Lilian I. https://orcid.org/0000-0002-9537-4544
Funding

Funding for this research was provided by:

U.S. Department of Health & Human Services | National Institutes of Health (R01-AR053643)

U.S. Department of Veterans Affairs (I01BX005154)

U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (R01-AG067997)
License Information

Text and Data Mining valid from 2023-05-17

Version of Record valid from 2023-05-17
More Information

Article History

Received: 2 December 2022

Revised: 8 February 2023

Accepted: 1 March 2023

First Online: 17 May 2023

Competing interests

: The authors have declared that they have no competing interests.

Document is current

Any future updates will be listed below